Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
BBOTCompany Name
BRIDGEBIO ONCOLOGY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBRIDGEBIO ONCOLOGY THERAPEUTICS INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BBOT - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | 0% | $ -97.71M | $ -224.9M |
| 3/31/2025 | 0% | $ -880.46K | $ -6.15M |
| 12/31/2024 | 0% | $ -763.82K | $ -3.73M |
| 9/30/2024 | 0% | $ -675.96K | $ -3.52M |
| 6/30/2024 | 0% | $ 0 | $ -3.37M |
| 3/31/2024 | 0% | $ 0 | $ -3.22M |
| 12/31/2023 | 0% | $ 0 | $ 6.53K |
| 9/30/2023 | 0% | $ 0 | $ 21.53M |
Key Performance Insights, Last 5 Years
- BRIDGEBIO ONCOLOGY THERAPEUTICS INC's latest trailing twelve months (TTM) CROIC stands at 0%.
- Over the past 5 years, BRIDGEBIO ONCOLOGY THERAPEUTICS INC's average CROIC has been 0%.
- The median CROIC for BRIDGEBIO ONCOLOGY THERAPEUTICS INC during this period was 0%
- BRIDGEBIO ONCOLOGY THERAPEUTICS INC reached its highest CROIC over the past 5 years at 0%.
- The lowest CROIC recorded by BRIDGEBIO ONCOLOGY THERAPEUTICS INC in the same timeframe 0%
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for BRIDGEBIO ONCOLOGY THERAPEUTICS INC is calculated as follows: FCF [ $ 0 ] / Inv. Capital [ $ 21.53M ]
(=) CROIC [ 0% ] BBOT - Cash Return on Invested Capital, Last 5 years
0%
Minimum
Dec 31, 2023
0%
Maximum
Dec 31, 2023
0%
Average
0%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.78% with a standard deviation of 15.05%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.3% |
| average | 2.78% |
| median | 4.97% |
| std | 15.05% |